Cleopatra Hospitals Group S.A.E. (EGX:CLHO)
Egypt · Delayed Price · Currency is EGP 17.40
-0.30 (-1.69%)
At close: Aug 5, 2026
EGX:CLHO Financials Overview
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7,581 | 7,227 | 5,420 | 3,595 | 2,584 | 2,549 |
Revenue Growth | 29.42% | 33.34% | 50.76% | 39.13% | 1.36% | 28.13% |
Gross Profit Gross Profit Growth | 2,889 | 2,858 | 2,013 | 1,209 | 865.27 | 930.67 |
Operating Income Operating Income Growth | 1,420 | 1,490 | 1,157 | 656.76 | 445.91 | 527.79 |
Net Income Net Income Growth | 587.34 | 669.82 | 567.29 | 319.58 | 257.81 | 321.12 |
Earnings Per Share EPS Growth | 0.40 | 0.46 | 0.39 | 0.22 | 0.17 | 0.20 |
EPS Growth | -0.02% | 17.95% | 77.27% | 30.17% | -15.50% | 33.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
CHG Pharma for Pharmacy Management CHG Pharma for Pharmacy Management Growth | 121.36 | 117.73 | 79.11 | 64.84 | 48.04 | 37.37 |
Elkateb Hospital Elkateb Hospital Growth | 356.14 | 350.39 | 238.27 | 134.61 | 49 | 110.22 |
Al Shorouk Hospital Al Shorouk Hospital Growth | 1,095 | 1,074 | 814.16 | 586.25 | 439.72 | 379.47 |
Consolidated Adjustment Consolidated Adjustment Growth | -197.23 | -191.17 | -160.91 | -61.18 | -27.29 | -36.52 |
CHG Medical Services CHG Medical Services Growth | 208.63 | 205.15 | 152.82 | 114.75 | 87.65 | 74.52 |
Cleopatra Heaven Cleopatra Heaven Growth | 428.03 | 404.52 | 248.17 | 64.56 | - | - |
CHG for Hospitals CHG for Hospitals Growth | 2.9 | 3.79 | 18.3 | - | - | 1.19 |
Cairo Specialised Hospital Cairo Specialised Hospital Growth | 1,634 | 1,579 | 1,179 | 774.21 | 525.56 | 458.92 |
Nile Badrawy Hospital Nile Badrawy Hospital Growth | 1,046 | 1,057 | 827.02 | 537.52 | 378.42 | 375.29 |
Cleopatra Hospital Company Cleopatra Hospital Company Growth | 2,559 | 2,461 | 1,910 | 1,296 | 1,014 | 935.17 |
Bedaya El Gedida for Medical Centers and Hospitals Bedaya El Gedida for Medical Centers and Hospitals Growth | 172.25 | 166.1 | 114.91 | 83.58 | 68.89 | 49.27 |
Total Total Growth | 7,581 | 7,227 | 5,420 | 3,595 | 2,584 | 2,549 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 749.58 | 547.54 | 473.22 | 357.9 | 346.14 | 845.98 |
Total Debt Total Debt Growth | 3,914 | 3,703 | 2,458 | 873.48 | 526.94 | 272.09 |
Net Cash (Debt) Net Cash Growth | -3,164 | -3,155 | -1,984 | -515.58 | -180.8 | 573.89 |
Net Cash Growth | - | - | - | - | - | 6.82% |
Net Cash Per Share Net Cash Per Share Growth | -2.19 | -2.19 | -1.37 | -0.36 | -0.12 | 0.36 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,889 | 1,892 | 1,500 | 557.96 | 439.87 | 648.16 |
Capital Expenditures CapEx Growth | -2,528 | -2,650 | -2,704 | -825.16 | -424.68 | -282.16 |
Free Cash Flow Free Cash Flow Growth | -638.89 | -758.57 | -1,204 | -267.2 | 15.19 | 365.99 |
Free Cash Flow Growth | - | - | - | - | -95.85% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.10% | 39.55% | 37.14% | 33.62% | 33.48% | 36.51% |
Operating Margin | 18.73% | 20.62% | 21.35% | 18.27% | 17.26% | 20.70% |
Pretax Margin | 16.05% | 18.25% | 19.99% | 16.94% | 17.48% | 20.97% |
Profit Margin | 7.75% | 9.27% | 10.47% | 8.89% | 9.98% | 12.60% |
FCF Margin | -8.43% | -10.50% | -22.21% | -7.43% | 0.59% | 14.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 43.51 | 28.56 | 20.51 | 21.35 | 29.81 | 24.24 |
Forward PE | 31.50 | 23.48 | 16.96 | 15.38 | 17.10 | 16.08 |
P/FCF Ratio | - | - | - | - | 505.76 | 21.27 |
PS Ratio | 3.33 | 2.65 | 2.15 | 1.90 | 2.97 | 3.05 |